市場調查報告書

表觀遺傳學的全球市場 - 各產品、各用途、各地區:市場規模與未來預測

Global Epigenetics Market, by Product, Application, Technology, by Region, Growth Potential, Trends Analysis, Competitive Market Size and Forecast, 2019-2025

出版商 Blueweave Consulting & Research Private Limited 商品編碼 833055
出版日期 內容資訊 英文 120 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
表觀遺傳學的全球市場 - 各產品、各用途、各地區:市場規模與未來預測 Global Epigenetics Market, by Product, Application, Technology, by Region, Growth Potential, Trends Analysis, Competitive Market Size and Forecast, 2019-2025
出版日期: 2019年03月25日內容資訊: 英文 120 Pages
簡介

本報告提供全球表觀遺傳學市場相關分析,市場基本結構和促進、阻礙因素,市場整體及各用途、各技術、各地區的趨勢預測 (過去4年、今後7年份),市場策略的趨勢與案例,主要企業的簡介等相關調查。

第1章 分析的組成架構

第2章 分析方法

第3章 摘要整理

第4章 產業分析

  • 產業的價值鏈分析
  • 對產業的影響力和推動因素
    • 成長促進因素
    • 產業的相關課題
    • 市場機會
  • 技術環境
  • 管理體制
  • 各企業的市場佔有率分析
  • 成長可能性分析
  • 策略展望
  • 波特的五力分析
  • PESTEL分析

第5章 全球表觀遺傳學市場:概要

  • 市場規模與其預測
    • 以金額為準
  • 市場佔有率與其預測
    • 各產品種類,各用途,各技術,各地區

第6章 全球表觀遺傳學市場:各產品種類

  • 各種類的主要趨勢
  • 套件
    • 市場規模的成果值、預測值 (以金額為準,總計11年份)
    • 市場規模的成果值、預測值:各地區 (以金額為準,總計11年份)
  • 試劑
  • 酵素
  • 次世代定序 (NGS)
  • 質譜儀 (集體分光儀)
  • 聚合酵素鏈鎖反應 (PCR)
  • 生物資訊學 (Bioinformatics)

第7章 全球表觀遺傳學市場:各用途

  • 各用途的主要趨勢
  • 腫瘤
  • 心臟疾病
  • 免疫

第8章 全球表觀遺傳學市場:各技術

  • 各技術的主要趨勢
  • DNA甲基化
  • 組蛋白修飾

第9章 全球表觀遺傳學市場:各地區

  • 各地區的主要趨勢
  • 北美市場
    • 市場規模的成果值、預測值 (以金額為準,總計11年份)
    • 市場規模的成果值、預測值:各產品種類 (以金額為準,總計11年份)
    • 市場規模的成果值、預測值:各技術 (以金額為準,總計11年份)
    • 市場規模的成果值、預測值:各用途 (以金額為準,總計11年份)
    • 市場規模的成果值、預測值:各國 (以金額為準,總計11年份)
  • 亞洲市場
  • 歐洲市場
  • 中東、非洲市場
  • 南美市場

第10章 企業簡介 (企業概要,財務指標矩陣,主要產品環境,企業員工,主要的競爭企業,聯繫資訊,SWOT分析,企業策略預測)

  • Illumina
  • Diagenode
  • QIAGEN
  • Merck Millipore
  • Abcam
  • Active Motif
  • New England Biolabs
  • Agilent
  • Zymo Research
  • PerkinElmer
  • Bio-Rad Roche Diagnostics
  • Thermo Fisher Scientific, Inc.,
  • Eisai
  • Novartis AG
目錄
Product Code: BWC19118

Rapid advancements in gene technology and advantages of R&D in cost-effective & efficient for less labor intensive will boost Epigenetics market in the upcoming year. Moreover, the major factor driving the market growth is the growing application of epidemics in non-oncology diseases, the rise in the number of research activities; and the augmentations in collaborations between the biotechnology, academic, and pharmaceutical organizations. Furthermore, the huge increment in cancer affected patients and the extensive requirement of medical equipment in developing countries is accelerating the growth of Epigenetics market.

Additionally, Epigenetics technology help in the fulfilment of clinical needs of patients and help in early diagnosis of cancer diseases will contribute to Epigenetics market growth during the forecast periods. Rise in geriatric population and growing awareness about early diagnosis are key driver aiding to the growth of Epigenetics Market. According to BlueWeave Consulting, The Global Epigenetics Market is expected to grow with a significant rate during the forecast period 2018-2025 owing to the increasing demand for epigenetics technology for curbing out cancer-related diseases.

Kit Product type of Epigenetics market is projected to be the leading segment of the overall market during the forecast period

On the basis of product type, the Epigenetics Market has been segmented into Kit, Enzymes, Reagent, NGS, Mass Spectrometer, PCR, and Bioinformatics. Kit segment dominates the global Epigenetics owing to its ready to use & flexibility features for detecting the cancer infected diseases. Reagent will be the fastest growing segment due to its application as primers, buffers, magnetic beads, antibodies, histones in epigenetics technology.

Oncology is projected to lead the industry for utilizing applications of the Epigenetics during the forecast period

On the basis of application, the global Epigenetics market has been segmented into Oncology, Cardiology, and Immunology. By application type, Oncology will lead the market owing to the rise in cancer infected diseases population coupled with advancements in cancer disease detecting devices. Cardiology is expected to grow at the fastest rate during the forecast period owing to the government's supports and huge R&D in the field of cancer-related diseases by pharmaceuticals companies.

DNA Methylation is expected to dominating technology for utilizing in Epigenetics segment during the forecast period

On the basis of Technology Type, the global Epigenetics market has been segmented into DNA Methylation, Histone Modification, and others. DNA Methylation is expected to dominate the market owing to the rise in cancer affected population coupled with its application to early detection of cancer diseases. Histone Modification market is expected to be the fastest growing market due to its huge usage in altering chromatin structure or recruiting histone modifiers.

Asia accounts for the lion's share of the global Epigenetics market during the anticipated period.

On the basis of region, the Epigenetics market has been segmented into North America, Europe, Asia Pacific, Middle East & Africa, and Latin America. North America dominates the global Epigenetics market over the forecast period owing to government encouragement through financial aid, rises in geriatric population and high awareness for technological advancements in genetic disease The Asia Pacific is estimated to witness the fastest growing market over the forecast period owing to augmentation in R&D infrastructure, encouragement by government initiatives, and diversified healthcare market.

Global Epigenetics Market Competitive Landscape

Companies, such as Illumina, Diagenode, QIAGEN, Merck Millipore, Abcam, Active Motif, New England Biolabs, Agilent, Zymo Research, PerkinElmer, Bio-Rad Roche Diagnostics, Thermo Fisher Scientific, Inc., Eisai Co. Ltd., and Novartis AG are the key players in manufacturing of Epigenetics products.

The in-depth analysis of the report provides the growth potential, upcoming trends and statistics of Global Epigenetics Market size & forecast. The report promises to provide state-of-the-art technology of Epigenetics production and industry insights which help decision makers to take sound strategic decisions. Furthermore, the report also analyzes the market drivers and challenges and competitive analysis of the market.

Table of Contents

1. Research Frame work

  • 1.1. Research Objective
  • 1.2. Market Definition and Scope
  • 1.3. Market segmentation

2. Research methodology

  • 2.1. Qualitative Research
    • 2.1.1. Primary & Secondary Sources
  • 2.2. Quantitative Research
    • 2.2.1. Primary & Secondary Sources
  • 2.3. Breakdown of Primary Research Respondents, By Region
    • 2.3.1. Secondary Research
    • 2.3.2. Primary Research
  • 2.4. Breakdown of Primary Research Respondents, By Industry Participants
  • 2.5. Market Size Estimation
  • 2.6. Assumption for the Study
  • 2.7. Market Breakdown & Data Triangulation

3. Executive Summary

4. Global Epigenetics Industry Insights

  • 4.1. Industry Value Chain analysis
  • 4.2. Industry impact and Forces
    • 4.2.1. Growth Drivers
    • 4.2.2. Industry Challenges
    • 4.2.3. opportunities
  • 4.3. Technological Landscape
  • 4.4. Regulatory Framework
  • 4.5. Company market share analysis,2018
  • 4.6. Growth potential analysis,2018
  • 4.7. Strategic Outlook
  • 4.8. Porter's analysis
  • 4.9. PESTEL analysis

5. Global Epigenetics Market Overview

  • 5.1. Market size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Type
    • 5.2.2. By Application
    • 5.2.3. By Technology
    • 5.2.4. By Region

6. Global Epigenetics Market, By Product Type

  • 6.1. Key Type Trends
  • 6.2. Kit
    • 6.2.1. Market estimates & forecast, 2015-2025, (USD Million)
    • 6.2.2. Market estimates & forecast, by region, 2015-2025, (USD Million)
  • 6.3. Reagent
    • 6.3.1. Market estimates & forecast, 2015-2025, (USD Million)
    • 6.3.2. Market estimates & forecast, by region, 2015-2025, (USD Million)
  • 6.4. Enzymes
    • 6.4.1. Market estimates & forecast, 2015-2025, (USD Million)
    • 6.4.2. Market estimates & forecast, by region, 2015-2025, (USD Million)
  • 6.5. NGS
    • 6.5.1. Market estimates & forecast, 2015-2025, (USD Million)
    • 6.5.2. Market estimates & forecast, by region, 2015-2025, (USD Million)
  • 6.6. Mass Spectrometer
    • 6.6.1. Market estimates & forecast, 2015-2025, (USD Million)
    • 6.6.2. Market estimates & forecast, by region, 2015-2025, (USD Million)
  • 6.7. PCR
    • 6.7.1. Market estimates & forecast, 2015-2025, (USD Million)
    • 6.7.2. Market estimates & forecast, by region, 2015-2025, (USD Million)
  • 6.8. Bioinformatics
    • 6.8.1. Market estimates & forecast, 2015-2025, (USD Million)
    • 6.8.2. Market estimates & forecast, by region, 2015-2025, (USD Million)

7. Global Epigenetics Market, By Applications

  • 7.1. Key market Trends
  • 7.2. Oncology
    • 7.2.1. Market estimates & forecast, 2015-2025, (USD Million)
    • 7.2.2. Market estimates & forecast, by region, 2015-2025, (USD Million)
  • 7.3. Cardiology
    • 7.3.1. Market estimates & forecast, 2015-2025, (USD Million)
    • 7.3.2. Market estimates & forecast, by region, 2015-2025, (USD Million)
  • 7.4. Immunology
    • 7.4.1. Market estimates & forecast, 2015-2025, (USD Million)
    • 7.4.2. Market estimates & forecast, by region, 2015-2025, (USD Million)

8. Global Epigenetics Market, By Technology

  • 8.1. Key market Trends
  • 8.2. DNA Methylation,
    • 8.2.1. Market estimates & forecast, 2015-2025, (USD Million)
    • 8.2.2. Market estimates & forecast, by region, 2015-2025, (USD Million)
  • 8.3. Histone Modification
    • 8.3.1. Market estimates & forecast, 2015-2025, (USD Million)
    • 8.3.2. Market estimates & forecast, by region, 2015-2025, (USD Million)

9. Global Epigenetics Market, By Region

  • 9.1. Key Regional Market trends
  • 9.2. North America
    • 9.2.1. Market estimates & forecast, 2015-2025, (USD Million)
    • 9.2.2. Market estimates & forecast by Product type, 2015-2025, (USD Million)
    • 9.2.3. Market estimates & forecast, by Technology , 2015-2025, (USD Million)
    • 9.2.4. Market estimates & forecast, by Applications, 2015-2025, (USD Million)
    • 9.2.5. Market estimates & forecast, by Country, 2015-2025, (USD Million)
  • 9.3. Asia
    • 9.3.1. Market estimates & forecast, 2015-2025, (USD Million)
    • 9.3.2. Market estimates & forecast by Product type, 2015-2025, (USD Million)
    • 9.3.3. Market estimates & forecast, by Technology , 2015-2025, (USD Million)
    • 9.3.4. Market estimates & forecast, by Applications, 2015-2025, (USD Million)
    • 9.3.5. Market estimates & forecast, by Country, 2015-2025, (USD Million)
  • 9.4. Europe
    • 9.4.1. Market estimates & forecast, 2015-2025, (USD Million)
    • 9.4.2. Market estimates & forecast by Product type, 2015-2025, (USD Million)
    • 9.4.3. Market estimates & forecast, by Technology , 2015-2025, (USD Million)
    • 9.4.4. Market estimates & forecast, by Applications, 2015-2025, (USD Million)
    • 9.4.5. Market estimates & forecast, by Country, 2015-2025, (USD Million)
  • 9.5. Middle East & Africa
    • 9.5.1. Market estimates & forecast, 2015-2025, (USD Million)
    • 9.5.2. Market estimates & forecast by Product type, 2015-2025, (USD Million)
    • 9.5.3. Market estimates & forecast, by Technology , 2015-2025, (USD Million)
    • 9.5.4. Market estimates & forecast, by Applications, 2015-2025, (USD Million)
    • 9.5.5. Market estimates & forecast, by Country, 2015-2025, (USD Million)
  • 9.6. Latin America
    • 9.6.1. Market estimates & forecast, 2015-2025, (USD Million)
    • 9.6.2. Market estimates & forecast by Product type, 2015-2025, (USD Million)
    • 9.6.3. Market estimates & forecast, by Technology , 2015-2025, (USD Million)
    • 9.6.4. Market estimates & forecast, by Applications, 2015-2025, (USD Million)
    • 9.6.5. Market estimates & forecast, by Country, 2015-2025, (USD Million)

10. Company Profiles (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, SWOT Analysis and Strategic Outlook)

  • 10.1. Illumina
  • 10.2. Diagenode
  • 10.3. QIAGEN
  • 10.4. Merck Millipore
  • 10.5. Abcam
  • 10.6. Active Motif
  • 10.7. New England Biolabs
  • 10.8. Agilent
  • 10.9. Zymo Research
  • 10.10. PerkinElmer
  • 10.11. Bio-Rad Roche Diagnostics
  • 10.12. Thermo Fisher Scientific, Inc.,
  • 10.13. Eisai Co. Ltd.
  • 10.14. Novartis AG
Back to Top